Need to solve manufacturing challenge: BioNTech CEO as vaccine gets US nod
BioNTech CEO Ugur Sahin has said that the company and its partner Pfizer need to solve the challenge of manufacturing after their COVID-19 vaccine was authorised for use by the US.



"We are dealing with that question - how to produce more doses," Sahin added. The US regulator FDA's emergency use authorisation is the "most important milestone", he further said.